The trading activity of members of Congress is closely monitored and investors are looking to see which Magnificent Seven stocks are most loved and which large-cap names are being bought and sold.



When it comes to a member of Congress buying up shares of small-cap stocks, investors may pay even closer attention.



 • Genprex stock is among today’s weakest performers. What’s behind GNPX decline?



<h2>Congressman Buys Small-Cap Stocks Again</h2>



Congressman Tim Moore (R-N.C.) made multiple trades in 2025, including buying shares of beaten-down restaurant company Cracker Barrel.



The congressman also bought shares of small-cap stocks and is back once again, adding stocks with low market capitalizations to his investment portfolio.



The latest disclosure shows the following trades, as reported by Quiver Quantitative.



<ul>
<li>Feb. 18: Sold $1,001 to $15,000 in Coinbase Global (NASDAQ:COIN) shares</li>



<li>Feb. 12: Bought $1,001 to $15,000 in Krispy Kreme (NASDAQ:DNUT) shares</li>



<li>Feb. 11: Bought $15,001 to $50,000 in Simply Good Foods (NASDAQ:SMPL) shares</li>



<li>Feb. 5: Bought $1,001 to $15,000 in Genprex Inc (NASDAQ:GNPX) shares</li>



<li>Feb. 3: Bought $15,001 to $50,000 in Simply Good Foods shares</li>



<li>Jan. 30: Sold $15,001 to $50,000 in AT&amp;T (NYSE:T) shares</li>



<li>Jan. 30: Sold $15,001 to $50,000 in Verizon Communications (NYSE:VZ) shares</li>



<li>Jan. 23: Bought $15,001 to $50,000 in Harley Davidson Inc. (NYSE:HOG) shares</li>
</ul>



The latest transactions include another buy of Genprex stock, a small gene therapy company that Moore also bought shares of in 2025. Genprex has a current market capitalization of $5.2 million.



Moore bought shares of Genprex on three occasions in 2025, with three purchases totaling $31,000 to $115,000 worth of shares in the small gene therapy company.



The other small-cap stock Moore is buying shares of is Simply Good Foods, with two purchases totaling $30,000 to $100,000.



Simply Good Foods has a current market capitalization of $1.6 billion. The stock is down 53% over the past 52 weeks, with shares down 15% year-to-date in 2026. Moore is the first member of Congress to buy the stock in recent years, according to data from Quiver Quantitative.



<h2>Moore's Trading History</h2>



Along with making headlines for buying and selling Cracker Barrel shares in 2025, Moore was noticed by Benzinga for his purchases in small-cap stocks such as Genprex and also for buying shares of Hyster-Yale Inc (NYSE:HY), a $680 million market capitalization lift truck company.



Moore was recently crowned as the top-performing member of Congress for stock trades in 2025 by Quiver Quantitative. The congressman gained 52% in 2025, outperforming other members of Congress and the S&amp;P 500's 16.6% gain.



Moore's past returns and the small sizes of several stocks mentioned above make the trades worth monitoring.



Photo: W. Scott McGill via Shutterstock

GNPX

COIN

DNUT

SMPL

Congressman Tim Moore (R-N.C.) is making headlines again for his stock trades in 2026, focusing on small-cap companies. He has recently bought shares in Genprex Inc and Simply Good Foods, alongside other trades including Krispy Kreme and Coinbase. Moore's trading history shows significant interest in small-cap stocks, having previously invested in Genprex and achieved a 52% gain in 2025, outperforming his peers and the S&P 500. Investors are advised to watch these stocks closely due to Moore's track record and the current market conditions.

- Congressman Tim Moore (R-N.C.) has been active in trading small-cap stocks, including significant purchases of Genprex and Simply Good Foods in 2025.  
- His trading activity has attracted attention, especially as he reported notable gains of 52% in 2025, outpacing both other Congress members and the S&P 500.  
- Investors are closely monitoring Moore's transactions and the performance of stocks he has invested in, particularly in the context of his focus on small-cap companies.

Congressman Who Bought Small-Cap Stocks In 2025 Is Back With New 2026 Pick: Here's What He's Buying